Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |